25 related articles for article (PubMed ID: 38484695)
1. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1.
Phin S; Kupferwasser D; Lam J; Lee-Fruman KK
Biochem J; 2003 Jul; 373(Pt 2):583-91. PubMed ID: 12713446
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.
Park IH; Bachmann R; Shirazi H; Chen J
J Biol Chem; 2002 Aug; 277(35):31423-9. PubMed ID: 12087098
[TBL] [Abstract][Full Text] [Related]
3. The polyproline-motif of S6K2: eIF5A translational dependence and importance for protein-protein interactions.
Meneguello L; Barbosa NM; Pereira KD; Proença ARG; Tamborlin L; Simabuco FM; Iwai LK; Zanelli CF; Valentini SR; Luchessi AD
J Cell Biochem; 2019 Apr; 120(4):6015-6025. PubMed ID: 30320934
[TBL] [Abstract][Full Text] [Related]
4. S6 kinase 2 promotes breast cancer cell survival via Akt.
Sridharan S; Basu A
Cancer Res; 2011 Apr; 71(7):2590-9. PubMed ID: 21427355
[TBL] [Abstract][Full Text] [Related]
5. Identification of the general transcription factor Yin Yang 1 as a novel and specific binding partner for S6 kinase 2.
Ismail HM; Myronova O; Tsuchiya Y; Niewiarowski A; Tsaneva I; Gout I
Cell Signal; 2013 May; 25(5):1054-63. PubMed ID: 23403125
[TBL] [Abstract][Full Text] [Related]
6. Computer-assisted discovery and evaluation of potential ribosomal protein S6 kinase beta 2 inhibitors.
Yu F; Wu X; Chen W; Yan F; Li W
Comput Biol Med; 2024 Apr; 172():108204. PubMed ID: 38484695
[TBL] [Abstract][Full Text] [Related]
7. S6K2 promises an important therapeutic potential for cancer.
Sever Nİ; Cengiz Şahin S
Future Oncol; 2019 Jan; 15(1):95-102. PubMed ID: 30730779
[TBL] [Abstract][Full Text] [Related]
8. Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer.
Sridharan S; Basu A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054043
[TBL] [Abstract][Full Text] [Related]
9. The S6K protein family in health and disease.
Tavares MR; Pavan IC; Amaral CL; Meneguello L; Luchessi AD; Simabuco FM
Life Sci; 2015 Jun; 131():1-10. PubMed ID: 25818187
[TBL] [Abstract][Full Text] [Related]
10. [Research progress of p70 ribosomal protein S6 kinase inhibitors].
Tu ZJ; Hu GY; Li QB
Yao Xue Xue Bao; 2015 Mar; 50(3):261-71. PubMed ID: 26118103
[TBL] [Abstract][Full Text] [Related]
11. p70 S6 kinase as a therapeutic target in cancers: More than just an mTOR effector.
Artemenko M; Zhong SSW; To SKY; Wong AST
Cancer Lett; 2022 Jun; 535():215593. PubMed ID: 35176419
[TBL] [Abstract][Full Text] [Related]
12. mTOR pathway and DNA damage response: A therapeutic strategy in cancer therapy.
Danesh Pazhooh R; Rahnamay Farnood P; Asemi Z; Mirsafaei L; Yousefi B; Mirzaei H
DNA Repair (Amst); 2021 Aug; 104():103142. PubMed ID: 34102579
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
